These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20517174)

  • 21. Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6.
    Mo SL; Liu YH; Duan W; Wei MQ; Kanwar JR; Zhou SF
    Curr Drug Metab; 2009 Sep; 10(7):730-53. PubMed ID: 19702527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel CYP2B6 enzyme variants in a Rwandese population: functional characterization and assessment of in silico prediction tools.
    Radloff R; Gras A; Zanger UM; Masquelier C; Arumugam K; Karasi JC; Arendt V; Seguin-Devaux C; Klein K
    Hum Mutat; 2013 May; 34(5):725-34. PubMed ID: 23418033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CYP2B6*6 allele significantly alters the N-demethylation of ketamine enantiomers in vitro.
    Li Y; Coller JK; Hutchinson MR; Klein K; Zanger UM; Stanley NJ; Abell AD; Somogyi AA
    Drug Metab Dispos; 2013 Jun; 41(6):1264-72. PubMed ID: 23550066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further characterization of the expression in liver and catalytic activity of CYP2B6.
    Ekins S; Vandenbranden M; Ring BJ; Gillespie JS; Yang TJ; Gelboin HV; Wrighton SA
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1253-9. PubMed ID: 9732386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of CYP2B6 G15631T polymorphism with acute leukemia susceptibility.
    Berköz M; Yalin S
    Leuk Res; 2009 Jul; 33(7):919-23. PubMed ID: 19144407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P450 2B6: function, genetics, and clinical relevance.
    Turpeinen M; Zanger UM
    Drug Metabol Drug Interact; 2012; 27(4):185-97. PubMed ID: 23152403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism.
    Crane AL; Klein K; Zanger UM; Olson JR
    Toxicology; 2012 Mar; 293(1-3):115-122. PubMed ID: 22281205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional characterization of single nucleotide polymorphisms with amino acid substitution in CYP1A2, CYP2A6, and CYP2B6 found in the Japanese population.
    Iwasaki M; Yoshimura Y; Asahi S; Saito K; Sakai S; Morita S; Takenaka O; Inoda T; Kashiyama E; Aoyama A; Nakabayashi T; Omori S; Kuwabara T; Izumi T; Nakamura K; Takanaka K; Nakayama Y; Takeuchi M; Nakamura H; Kametani S; Terauchi Y; Hashizume T; Nagayama S; Kume T; Achira M; Kawai H; Kawashiro T; Nakamura A; Nakai Y; Kagayama A; Shiraga T; Niwa T; Yoshimura T; Morita J; Ohsawa F; Tani M; Osawa N; Ida K; Noguchi K
    Drug Metab Pharmacokinet; 2004 Dec; 19(6):444-52. PubMed ID: 15681899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese.
    Guan S; Huang M; Chan E; Chen X; Duan W; Zhou SF
    Eur J Pharm Sci; 2006 Sep; 29(1):14-21. PubMed ID: 16815693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
    Yanagihara Y; Kariya S; Ohtani M; Uchino K; Aoyama T; Yamamura Y; Iga T
    Drug Metab Dispos; 2001 Jun; 29(6):887-90. PubMed ID: 11353758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.
    Faucette SR; Hawke RL; Lecluyse EL; Shord SS; Yan B; Laethem RM; Lindley CM
    Drug Metab Dispos; 2000 Oct; 28(10):1222-30. PubMed ID: 10997944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of cyclophosphamide activation by CYP2B6 mutants: from in silico to ex vivo.
    Nguyen TA; Tychopoulos M; Bichat F; Zimmermann C; Flinois JP; Diry M; Ahlberg E; Delaforge M; Corcos L; Beaune P; Dansette P; André F; de Waziers I
    Mol Pharmacol; 2008 Apr; 73(4):1122-33. PubMed ID: 18212249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda.
    Penzak SR; Kabuye G; Mugyenyi P; Mbamanya F; Natarajan V; Alfaro RM; Kityo C; Formentini E; Masur H
    HIV Med; 2007 Mar; 8(2):86-91. PubMed ID: 17352764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.
    Sridar C; Kenaan C; Hollenberg PF
    Drug Metab Dispos; 2012 Dec; 40(12):2256-66. PubMed ID: 22936314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients.
    Nakajima M; Komagata S; Fujiki Y; Kanada Y; Ebi H; Itoh K; Mukai H; Yokoi T; Minami H
    Pharmacogenet Genomics; 2007 Jun; 17(6):431-45. PubMed ID: 17502835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple novel nonsynonymous CYP2B6 gene polymorphisms in Caucasians: demonstration of phenotypic null alleles.
    Lang T; Klein K; Richter T; Zibat A; Kerb R; Eichelbaum M; Schwab M; Zanger UM
    J Pharmacol Exp Ther; 2004 Oct; 311(1):34-43. PubMed ID: 15190123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haplotype structure and allele frequencies of CYP2B6 in a Korean population.
    Cho JY; Lim HS; Chung JY; Yu KS; Kim JR; Shin SG; Jang IJ
    Drug Metab Dispos; 2004 Dec; 32(12):1341-4. PubMed ID: 15383491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development of a cocktail CYP2B6, CYP2C8, and CYP3A5 inhibition assay and a preliminary assessment of utility in a drug discovery setting.
    O'Donnell CJ; Grime K; Courtney P; Slee D; Riley RJ
    Drug Metab Dispos; 2007 Mar; 35(3):381-5. PubMed ID: 17142561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation of a single residue (K262R) in P450 2B6 leads to loss of mechanism-based inactivation by phencyclidine.
    Shebley M; Hollenberg PF
    Drug Metab Dispos; 2007 Aug; 35(8):1365-71. PubMed ID: 17460030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P450 polymorphisms and the response of lupus nephritis to cyclophosphamide therapy.
    Winoto J; Song H; Hines C; Nagaraja H; Rovin BH
    Clin Nephrol; 2011 May; 75(5):451-7. PubMed ID: 21543025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.